EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Implications of Gut Microbiota-Derived Metabolites in Neurological Disorders

Nishu Dalal, Jyoti Jaiswal, Manish Kushwaha, Harsha Verma iD, Payal Rana, Sarika Gupta, Rakhi Panwar, Preeti Janmeda, Poorvi Jain, Akhilesh Kumar Singh, Anand Mohan, Anil Kumar iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00414 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Nishu Dalal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gene Regulation Laboratory, National Institute of Immunology, New Delhi 110067, India. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Nervous System Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 105 Literaturangaben. Gefördert von: National Institute of Immunology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurological disorders (NDs) represent a significant global health challenges, with neurodegeneration being a common pathological feature. Recent investigations indicate the involvement of gut microbiota-derived metabolites in these disorders, such as neuroinflammation, oxidative stress, and cognitive decline. The gut-brain axis, a communication network between the gut and the central nervous system (CNS), is influenced by microbial metabolites, which can cross the blood-brain barrier and impact brain function. Key metabolites such as trimethylamine N-oxide (TMAO), para-cresol sulfate (pCS), 4-ethylphenyl sulfate (4-EPS), and indoxyl sulfate (IS) have been linked with the progression of neurological disorders. TMAO disrupts blood-brain barrier integrity, promotes oxidative stress, and activates microglial cells, which lead to the apoptosis of neurons, resulting in neuroinflammation. This could also result in psychiatric changes and behavioral disorders. pCS produced from gut bacteria metabolizing dietary proteins is correlated with amplified oxidative stress, neuroinflammation, and cognitive impairments in disorders like Parkinson's disease and Alzheimer's disease. Similarly, elevated 4-EPS levels are linked to autism spectrum disorder, contributing to anxiety-like behavior and blood-brain barrier disruption. Understanding the mechanisms by which gut-derived metabolites affect neurological health could lead to novel therapeutic strategies that can target gut microbiota for the medication and treatment of neurological disorders. Dietary precursors and gut microbiota metabolites, modulated by probiotics, prebiotics, postbiotics, and synbiotics, play a critical role in maintaining microbiota homeostasis and influencing neurological health, needing sophisticated biosensors to enable real-time monitoring and early intervention in disorders linked to gut metabolite imbalances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeNervous System DiseasesHumansAnimalsMethylaminesBlood-Brain BarrierCresolsOxidative StressBrainNeuroinflammatory Diseases

Stichwörter der Autor:innen

4-ethylphenyl sulfateindoxyl sulfateneuroinflammationneurological disorderspara-cresol sulfatetrimethylamine N-oxide

Substanzen

MethylaminesCresolstrimethyloxamine

Autor:innen und Institutionen

  • Gene Regulation Laboratory, National Institute of Immunology, New Delhi 110067, India.
  • Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
  • School of Life Science, Department of Biotechnology, Mahatma Gandhi Central University, Motihari, Bihar 845401, India.
  • Pt. Ravishankar Shukla University, Raipur, Chhattisgarh 492010, India.
  • Banasthali vidyapith, Jaipur, Rajasthan 304022, India.
  • Guru Jambheshwar University of Science and Technology, Hisar, Haryana 125001, India.

ORCID-Profile: Harsha Verma, Anil Kumar

Förderung

  • National Institute of Immunology

Zitieren

APA

Dalal, N., Jaiswal, J., Kushwaha, M., Verma, H., Rana, P., Gupta, S., Panwar, R., Janmeda, P., Jain, P., Singh, A. K., Mohan, A., & Kumar, A. (2025). Implications of Gut Microbiota-Derived Metabolites in Neurological Disorders. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00414

Vancouver

Dalal N, Jaiswal J, Kushwaha M, Verma H, Rana P, Gupta S, et al. Implications of Gut Microbiota-Derived Metabolites in Neurological Disorders. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00414

BibTeX
@article{Dalal2025,
  author = {Dalal, Nishu and Jaiswal, Jyoti and Kushwaha, Manish and Verma, Harsha and Rana, Payal and Gupta, Sarika and Panwar, Rakhi and Janmeda, Preeti and Jain, Poorvi and Singh, Akhilesh Kumar and Mohan, Anand and Kumar, Anil},
  title = {Implications of Gut Microbiota-Derived Metabolites in Neurological Disorders},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00414}
}
Kostenlos starten →